Holen Sie sich die Stockscreener-App
8.71
4.39%
-0.40
Handel nachbörslich:
8.71
Schlusskurs vom Vortag:
$9.11
Offen:
$8.62
24-Stunden-Volumen:
3,870
Relative Volume:
0.17
Marktkapitalisierung:
$13.38M
Einnahmen:
$630.00K
Nettoeinkommen (Verlust:
$5.72M
KGV:
-25.51
EPS:
-0.3415
Netto-Cashflow:
$-6.75M
1W Leistung:
-12.21%
1M Leistung:
-5.33%
6M Leistung:
+7.93%
1J Leistung:
-18.60%
1-Tages-Spanne:
$8.6001
$8.9275
1-Wochen-Bereich:
$8.6001
$9.83
52-Wochen-Spanne:
$6.51
$12.05
Addex Therapeutics Ltd Adr Stock (ADXN) Company Profile
Firmenname
Addex Therapeutics Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie ADXN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADXN
Addex Therapeutics Ltd Adr
|
8.71 | 8.45M | 630.00K | 5.72M | -6.75M | -0.3415 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Addex Therapeutics Ltd Adr Stock (ADXN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-31 | Hochstufung | H.C. Wainwright | Neutral → Buy |
Addex Therapeutics Ltd Adr Aktie (ADXN) Neueste Nachrichten
Short Interest in Addex Therapeutics Ltd. Sponsored ADR (NASDAQ:ADXN) Grows By 61.0% - Defense World
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Addex Therapeutics Ltd. Sponsored ADR (NASDAQ:ADXN) Short Interest Down 91.1% in September - Defense World
Revenue per share of Addex Therapeutics Ltd Sponsored ADR – BER:APE1 - TradingView
Addex Therapeutics Earnings Call: Strategic Gains Amid Challenges - MSN
Addex Therapeutics (NASDAQ:ADXN) Shares Up 5.6% – Here’s What Happened - Defense World
Addex Therapeutics’ (ADXN) “Sell (E+)” Rating Reaffirmed at Weiss Ratings - Defense World
Addex Therapeutics Ltd. Sponsored ADR (NASDAQ:ADXN) Sees Significant Increase in Short Interest - Defense World
Addex Therapeutics Reports Significant Loss Amid Financial Challenges - TipRanks
Addex Therapeutics H1 2025 Earnings Call Transcript - MarketBeat
Will V.F. Corporation (VFP) stock see valuation expansionExit Point & AI Driven Stock Movement Reports - newser.com
Addex Therapeutics (NASDAQ:ADXN) Shares Down 6.5% – What’s Next? - Defense World
Lion Group (NASDAQ:LGHL) Stock Price Down 4.3% – Here’s Why - Defense World
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - MSN
Can trapped investors hope for a rebound in Vine Hill Capital Investment Corp.Quarterly Profit Report & Pattern Based Trade Signal System - newser.com
Applying sector rotation models to Quipt Home Medical Corp.Portfolio Profit Report & Expert Verified Stock Movement Alerts - newser.com
Is This The Best Time To Buy iSpecimen Inc (NASDAQ: ISPC) Stock? - stocksregister.com
How to read the order book for Addex Therapeutics Ltd Depositary ReceiptInsider Buying & Long Hold Capital Preservation Plans - Newser
What earnings revisions data tells us about Core Scientific Inc.Earnings Summary Report & Daily Stock Momentum Reports - Newser
Strategies to average down on Addex Therapeutics Ltd Depositary ReceiptPortfolio Return Report & Weekly High Conviction Trade Ideas - Newser
Should you hold or exit SONY nowExit Point & Intraday High Probability Setup Alerts - Newser
Can trapped investors hope for a rebound in Titan Machinery Inc.Earnings Recap Summary & AI Enhanced Execution Alerts - Newser
Real time pattern detection on Grayscale Bitcoin Mini Trust stock3-Day Market Movement Forecast Analysis - Newser
Can GSK plc ADRhedged hit a new high this monthSmart Entry Signals for Active Traders - Newser
Combining price and volume data for Flux Power Holdings Inc.Free AI Driven Stock Trend Forecast - Newser
Most active stocks: US stocks with the highest trading volume today - Yahoo.co
Addex Therapeutics (NASDAQ:ADXN) Stock Price Down 4.5% – Here’s Why - Defense World
ADR Ratio Change - Yahoo
Addex Therapeutics Reports Q1 2025 Financial Results - TipRanks
Earnings call transcript: Addex Therapeutics highlights Q1 2025 progress - Investing.com
Addex Therapeutics to Release Q1 2025 Financial Results and Host Conference Call on June 19, 2025 - GlobeNewswire Inc.
European Equities See Growth In US ADR Market - Finimize
Addex Raises $10.0 Million In Equity Financing - Barchart.com
Addex Therapeutics Earnings Call: Strategic Gains Amid Financial Challenges - TipRanks
Addex Therapeutics Reports Strong 2024 Financial Turnaround - TipRanks
Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year? - Nasdaq
Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Addex Stock Soars on Crucial Update From Indivior Research Deal - Yahoo Finance
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? - Nasdaq
Is Alcon (ALC) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Addex Therapeutics (ADXN) Stock Forecast and Price Target 2025 - MarketBeat
Earnings call: Addex Therapeutics reports on collaborations and financials - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
Addex Therapeutics earnings matched, revenue topped estimates - Investing.com India
Where to Find Earnings Call Transcripts - MarketBeat
Addex Therapeutics (ADXN) Stock Rallied 62.1% on Phase 2 Study - AskTraders.com
Addex Therapeutics Ltd. Sponsored ADR (ADXN) Reports Q3 Loss, Tops Revenue Estimates - Nasdaq
Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici
Addex (ADXN) Terminates Parkinson's-Related Dyskinesia Study - Nasdaq
Addex To Present At The H.C. Wainwright BIOCONNECT Virtual Conference - Barchart.com
Finanzdaten der Addex Therapeutics Ltd Adr-Aktie (ADXN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):